F18.121

Clinical Causes: Recreational or experimental use of inhalants such as volatile solvents, aerosols, gases, and nitrites. Peer pressure or social influences encouraging inhalant use, especially among adolescents and young adults. Underlying mental health issues prompting self-medication with inhalants to manage stress, anxiety, or depression. Availability and accessibility of inhalants in household products like glues, paints, or cleaning agents. Lack of awareness regarding the health risks and potential for dependency or severe health consequences.

Key Symptoms: Confusion or disorientation Hallucinations or visual disturbances Altered consciousness Impaired motor coordination Mood swings or agitation Slurred speech Dizziness or lightheadedness Nausea or vomiting Weakness or fatigue Sweating or flushing

Diagnosis Path: Diagnosis typically involves a thorough medical history, including recent inhalant use, combined with physical examinations and neurological assessments. Healthcare providers may perform blood and urine tests to detect the presence of inhalant substances or their metabolites. Observation of mental status changes and behavioral signs helps determine the severity of intoxication and delirium. Laboratory and mental health evaluations assist clinicians in differentiating inhalant intoxication from other neurological or psychiatric conditions.

Treatment Protocols: Treatment for inhalant abuse with intoxication delirium aims to stabilize the patient's physical and mental health. Immediate interventions often include controlling agitation, preventing injury, and providing supportive care such as hydration and monitoring vital signs. In cases of severe intoxication, hospitalization may be necessary. Long-term treatment involves counseling, behavioral therapy, and addressing underlying psychological issues. Preventative measures focus on education about the dangers of inhalant abuse and support for individuals seeking to stop using these substances.